(Q46830133)

25 December 2017

http://europepmc.org/abstract/MED/27631879

title

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations (English)

1 reference

25 December 2017

http://europepmc.org/abstract/MED/27631879

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Coral Sanfeliu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Marta Cosín-Tomás

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Anna Antonell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mario Ezquerra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Raquel Sanchez-Valle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

José Luis Molinuevo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Albert Lladó

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Juan Fortea

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Albert Lleó

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Maria José Martí

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mercè Pallàs

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Perla Kaliman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

8 September 2016

1 reference

25 December 2017

http://europepmc.org/abstract/MED/27631879

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

5550-5562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

Early-stage and preclinical Alzheimer disease

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

The A4 study: stopping AD before symptoms begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Extracellular microRNAs as Biomarkers in Human Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs in learning, memory, and neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Epigenetically regulated microRNAs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Pathogenetic and therapeutic applications of microRNAs in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

The emerging role of microRNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Secretion of microvesicular miRNAs in cellular and organismal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Secretory microRNAs as a versatile communication tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Plasma microRNA biomarkers for detection of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating miR-125b as a biomarker of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating miRNA biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

The biomarker and therapeutic potential of miRNA in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Non-coding RNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

A blood based 12-miRNA signature of Alzheimer disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Methodological challenges in utilizing miRNAs as circulating biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Comparison of Eight Computer Programs for Receiver-Operating Characteristic Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Challenges in using circulating miRNAs as cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Analysis of circulating microRNA: preanalytical and analytical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Comparing the MicroRNA spectrum between serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Plasma processing conditions substantially influence circulating microRNA biomarker levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Modulation of SIRT1 expression in different neurodegenerative models and human pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Expression, regulation and function of microRNAs in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Identifying and validating biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Environmental control of microRNAs in the nervous system: Implications in plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs associated with exercise and diet: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Circulating microRNAs in response to exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

MicroRNA expression altered by diet: can food be medicinal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0088-8

[Preanalytical guidelines for clinical proteomics investigation of biological fluids]

21 January 2018

1 reference

12 December 2020

Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.

1 reference

12 December 2020

Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.

1 reference

12 December 2020

MicroRNA: Small RNA mediators of the brains genomic response to environmental stress

1 reference

12 December 2020

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening

1 reference

12 December 2020

Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells.

1 reference

12 December 2020

1 reference

12 December 2020

Understanding receiver operating characteristic (ROC) curves

1 reference

12 December 2020

MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.

1 reference

12 December 2020

Pathogenic microRNAs Common to Brain and Retinal Degeneration; Recent Observations in Alzheimer's Disease and Age-Related Macular Degeneration

1 reference

12 December 2020

Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis

1 reference

12 December 2020

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

1 reference

12 December 2020

Secreted microRNAs: a new form of intercellular communication

1 reference

12 December 2020

Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise.

1 reference

12 December 2020

Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes

1 reference

12 December 2020

Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers

1 reference

12 December 2020

Epigenetic mechanisms in Alzheimer's disease

1 reference

12 December 2020

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

1 reference

12 December 2020

SIRT1 in the brain-connections with aging-associated disorders and lifespan

1 reference

12 December 2020

Understanding microRNAs in neurodegeneration

1 reference

12 December 2020

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12035-016-0088-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27631879%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference